Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG. | J Clin Lab Anal | 2022 | 35243688 | PubTator, text mining | PubMed |
| The individual and global impact of copy-number variants on complex human traits. | Am J Hum Genet | 2022 | 35240056 | PubTator, text mining | PubMed |
| Distribution of ABO and Rh-D Blood Group Antigens Among Blood Donors in the Amhara Regional State, Ethiopia. | J Blood Med | 2022 | 35237083 | PubTator, text mining | PubMed |
| Implementation of Low Titer Whole Blood for French overseas operations: O positive or negative products in massive hemorrhage? | Transfus Clin Biol | 2022 | 35231634 | PubTator, text mining | PubMed |
| Immunochromatographic and microscopic detection of Plasmodium falciparum in recipients of P. falciparum-infected donor blood. | Parasitol Res | 2022 | 35230548 | PubTator, text mining | PubMed |
| Following targeted routine antenatal anti-D prophylaxis, almost half of the pregnant women had undetectable anti-D prophylaxis at delivery. | Acta Obstet Gynecol Scand | 2022 | 35224728 | PubTator, text mining | PubMed |
| Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response. | Clin Immunol | 2022 | 35218964 | PubTator, text mining | PubMed |
| Ginsenoside Rh4 Suppressed Metastasis of Lung Adenocarcinoma via Inhibiting JAK2/STAT3 Signaling. | Int J Mol Sci | 2022 | 35216134 | PubTator, text mining | PubMed |
| Straight to the Point-The Novel Strategies to Cure Pediatric AML. | Int J Mol Sci | 2022 | 35216084 | PubTator, text mining | PubMed |
| DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation. | Viruses | 2022 | 35215908 | PubTator, text mining | PubMed |
| Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms. | Medicina (Kaunas) | 2022 | 35208534 | PubTator, text mining | PubMed |
| Canine Distemper Virus in Wild Carnivore Populations from the Czech Republic (2012-2020): Occurrence, Geographical Distribution, and Phylogenetic Analysis. | Life (Basel) | 2022 | 35207575 | PubTator, text mining | PubMed |
| The power of the (imperfect) palindrome: Sequence-specific roles of palindromic motifs in gene regulation. | Bioessays | 2022 | 35195290 | PubTator, text mining | PubMed |
| Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn. | J Perinatol | 2022 | 35194159 | PubTator, text mining | PubMed |
| Quercetin induces pannexin 1 expression via an alternative transcript with a translationally active 5' leader in rhabdomyosarcoma. | Oncogenesis | 2022 | 35194046 | PubTator, text mining | PubMed |
| Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks' gestational age: A retrospective cohort study. | Contraception | 2022 | 35192809 | PubTator, text mining | PubMed |
| Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study. | Br J Haematol | 2022 | 35179784 | PubTator, text mining | PubMed |
| The distribution of ABO RhD blood groups in Australia, based on blood donor and blood sample pathology data. | Med J Aust | 2022 | 35172375 | PubTator, text mining | PubMed |
| Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies. | Transfusion | 2022 | 35170037 | PubTator, text mining | PubMed |
| Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection? | Bosn J Basic Med Sci | 2022 | 35150477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=48